Search Results - Nichols, Erin
- Showing 1 - 20 results of 22
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
All-trans retinoic acid and rapamycin synergize with transforming growth factor-β1 to induce regulatory T cells but confer different migratory capacities by Jhunjhunwala, Siddharth, Chen, Leo C., Nichols, Erin E., Thomson, Angus W., Raimondi, Giorgio, Little, Steven R.
Published 2013Text -
7
-
8
-
9
-
10
Evaluation of approaches to strengthen civil registration and vital statistics systems: A systematic review and synthesis of policies in 25 countries by Suthar, Amitabh Bipin, Khalifa, Aleya, Yin, Sherry, Wenz, Kristen, Ma Fat, Doris, Mills, Samuel Lantei, Nichols, Erin, AbouZahr, Carla, Mrkic, Srdjan
Published 2019Text -
11
Suspected Outbreak of Riboflavin Deficiency among Populations Reliant on Food Assistance: A Case Study of Drought-Stricken Karamoja, Uganda, 2009–2010 by Nichols, Erin K., Talley, Leisel E., Birungi, Nelly, McClelland, Amanda, Madraa, Elizabeth, Chandia, Agnes B., Nivet, Jacqueline, Flores-Ayala, Rafael, Serdula, Mary K.
Published 2013Text -
12
Household Transmission of Ebola Virus: Risks and Preventive Factors, Freetown, Sierra Leone, 2015 by Reichler, Mary R., Bangura, James, Bruden, Dana, Keimbe, Charles, Duffy, Nadia, Thomas, Harold, Knust, Barbara, Farmar, Ishmail, Nichols, Erin, Jambai, Amara, Morgan, Oliver, Hennessy, Thomas
Published 2018Text -
13
The WHO 2016 verbal autopsy instrument: An international standard suitable for automated analysis by InterVA, InSilicoVA, and Tariff 2.0 by Nichols, Erin K., Byass, Peter, Chandramohan, Daniel, Clark, Samuel J., Flaxman, Abraham D., Jakob, Robert, Leitao, Jordana, Maire, Nicolas, Rao, Chalapati, Riley, Ian, Setel, Philip W.
Published 2018Text -
14
Integrating community-based verbal autopsy into civil registration and vital statistics (CRVS): system-level considerations by de Savigny, Don, Riley, Ian, Chandramohan, Daniel, Odhiambo, Frank, Nichols, Erin, Notzon, Sam, AbouZahr, Carla, Mitra, Raj, Cobos Muñoz, Daniel, Firth, Sonja, Maire, Nicolas, Sankoh, Osman, Bronson, Gay, Setel, Philip, Byass, Peter, Jakob, Robert, Boerma, Ties, Lopez, Alan D.
Published 2017Text -
15
A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1–3 inhibitor, cediranib, in recurrent women’s cancers with biomarker... by Zimmer, Alexandra S., Nichols, Erin, Cimino-Mathews, Ashley, Peer, Cody, Cao, Liang, Lee, Min-Jung, Kohn, Elise C., Annunziata, Christina M., Lipkowitz, Stanley, Trepel, Jane B., Sharma, Rajni, Mikkilineni, Lekha, Gatti-Mays, Margaret, Figg, William D., Houston, Nicole D., Lee, Jung-Min
Published 2019Text -
16
Mortality surveillance during the COVID-19 pandemic by Setel, Philip, AbouZahr, Carla, Atuheire, Emily B, Bratschi, Martin, Cercone, Emily, Chinganya, Oliver, Clapham, Benjamin, Clark, Samuel J, Congdon, Carlie, de Savigny, Don, Karpati, Adam, Nichols, Erin, Jakob, Robert, Mwanza, James, Muhwava, William, Nahmias, Petra, Ortiz, Elizabeth M, Tshangela, Akhona
Published 2020Text -
17
Combination of PARP inhibitor olaparib, and PD-L1 inhibitor durvalumab, in recurrent ovarian cancer: a proof-of-concept phase 2 study by Lampert, Erika J., Zimmer, Alexandra, Padget, Michelle, Cimino-Mathews, Ashley, Nair, Jayakumar, Liu, Yingmiao, Swisher, Elizabeth M., Hodge, James W., Nixon, Andrew B., Nichols, Erin, Bagheri, Mohammad H., Levy, Elliott, Radke, Marc R., Lipkowitz, Stanley, Annunziata, Christina M., Taube, Janis M., Steinberg, Seth M., Lee, Jung-Min
Published 2020Text -
18
Estimating causes of death where there is no medical certification: evolution and state of the art of verbal autopsy by Chandramohan, Daniel, Fottrell, Edward, Leitao, Jordana, Nichols, Erin, Clark, Samuel J., Alsokhn, Carine, Cobos Munoz, Daniel, AbouZahr, Carla, Di Pasquale, Aurelio, Mswia, Robert, Choi, Eungang, Baiden, Frank, Thomas, Jason, Lyatuu, Isaac, Li, Zehang, Larbi-Debrah, Patrick, Chu, Yue, Cheburet, Samuel, Sankoh, Osman, Mohamed Badr, Azza, Fat, Doris Ma, Setel, Philip, Jakob, Robert, de Savigny, Don
Published 2022Text -
19
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations by Karzai, Fatima, VanderWeele, David, Madan, Ravi A., Owens, Helen, Cordes, Lisa M., Hankin, Amy, Couvillon, Anna, Nichols, Erin, Bilusic, Marijo, Beshiri, Michael L., Kelly, Kathleen, Krishnasamy, Venkatesh, Lee, Sunmin, Lee, Min-Jung, Yuno, Akira, Trepel, Jane B., Merino, Maria J., Dittamore, Ryan, Marté, Jennifer, Donahue, Renee N., Schlom, Jeffrey, Killian, Keith J., Meltzer, Paul S., Steinberg, Seth M., Gulley, James L., Lee, Jung-Min, Dahut, William L.
Published 2018Text -
20
Revising the WHO verbal autopsy instrument to facilitate routine cause-of-death monitoring by Leitao, Jordana, Chandramohan, Daniel, Byass, Peter, Jakob, Robert, Bundhamcharoen, Kanitta, Choprapawon, Chanpen, de Savigny, Don, Fottrell, Edward, França, Elizabeth, Frøen, Frederik, Gewaifel, Gihan, Hodgson, Abraham, Hounton, Sennen, Kahn, Kathleen, Krishnan, Anand, Kumar, Vishwajeet, Masanja, Honorati, Nichols, Erin, Notzon, Francis, Rasooly, Mohammad Hafiz, Sankoh, Osman, Spiegel, Paul, AbouZahr, Carla, Amexo, Marc, Kebede, Derege, Alley, William Soumbey, Marinho, Fatima, Ali, Mohamed, Loyola, Enrique, Chikersal, Jyotsna, Gao, Jun, Annunziata, Giuseppe, Bahl, Rajiv, Bartolomeus, Kidist, Boerma, Ties, Ustun, Bedirhan, Chou, Doris, Muhe, Lulu, Mathai, Matthews
Published 2013Text